Lv3
220 积分 2023-06-29 加入
A way to resource is a big power to success.
Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data
18天前
已完结
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
18天前
已完结
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial
18天前
已完结
Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
18天前
已完结
The Role of JAK Inhibitors in the Treatment of Cutaneous Lupus Erythematosus: A Review
25天前
已关闭
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis
1个月前
已完结
Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis
1个月前
已完结
Research progress of metabolomics in psoriasis
1个月前
已完结
Associations between body mass index and all-cause mortality among individuals with psoriasis: results from the NHANES database retrospective cohort study
2个月前
已完结
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
2个月前
已完结
皖公网安备34019202002308
